These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17024439)

  • 1. Clear graft survival and immune reactions following emergency keratoplasty.
    Maier P; Böhringer D; Reinhard T
    Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):351-9. PubMed ID: 17024439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study.
    Szaflik JP; Major J; Izdebska J; Lao M; Szaflik J
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):307-14. PubMed ID: 26553197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial.
    Reinhard T; Reis A; Böhringer D; Malinowski M; Voiculescu A; Heering P; Godehardt E; Sunmacher R
    Graefes Arch Clin Exp Ophthalmol; 2001 Jun; 239(5):367-72. PubMed ID: 11482341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preventive systemic cyclosporin A after keratoplasty at increased risk for immune reactions as the only elevated risk factor].
    Reinhard T; Sundmacher R; Godehardt E; Heering P
    Ophthalmologe; 1997 Jul; 94(7):496-500. PubMed ID: 9333395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study.
    Birnbaum F; Böhringer D; Sokolovska Y; Sundmacher R; Reinhard T
    Transplantation; 2005 Apr; 79(8):964-8. PubMed ID: 15849551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis.
    Maier AK; Ozlügedik S; Rottler J; Heussen FM; Klamann MK; Huber KK; Joussen AM; Winterhalter S
    Cornea; 2011 Dec; 30(12):1398-405. PubMed ID: 21996945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency.
    Reinhard T; Spelsberg H; Henke L; Kontopoulos T; Enczmann J; Wernet P; Berschick P; Sundmacher R; Böhringer D
    Ophthalmology; 2004 Apr; 111(4):775-82. PubMed ID: 15051212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged organ culture reduces the incidence of endothelial immune reactions.
    Maier P; Heinzelmann S; Böhringer D; Reinhard T
    Eye (Lond); 2016 Jan; 30(1):127-32. PubMed ID: 26493031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third or greater penetrating keratoplasties: indications, survival, and visual outcomes.
    Yildiz EH; Hoskins E; Fram N; Rapuano CJ; Hammersmith KM; Laibson PR; Cohen EJ
    Cornea; 2010 Mar; 29(3):254-9. PubMed ID: 20118784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of tissue quality parameters for donor corneas, designated for emergency cases: corneal graft survival.
    Rijneveld WJ; Wolff R; Völker-Dieben HJ; Pels E
    Acta Ophthalmol; 2011 Dec; 89(8):734-40. PubMed ID: 20039852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications and outcomes of keratoplasties in children during a 40-year period.
    Majander A; Kivelä TT; Krootila K
    Acta Ophthalmol; 2016 Sep; 94(6):618-24. PubMed ID: 27061670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of glaucoma history on graft survival after penetrating keratoplasty.
    Reinhard T; Kallmann C; Cepin A; Godehardt E; Sundmacher R
    Graefes Arch Clin Exp Ophthalmol; 1997 Sep; 235(9):553-7. PubMed ID: 9342604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of lamellar and penetrating keratoplasty outcomes: a registry study.
    Coster DJ; Lowe MT; Keane MC; Williams KA;
    Ophthalmology; 2014 May; 121(5):979-87. PubMed ID: 24491643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetrating keratoplasty in patients with atopic dermatitis with and without systemic cyclosporin A.
    Reinhard T; Möller M; Sundmacher R
    Cornea; 1999 Nov; 18(6):645-51. PubMed ID: 10571292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute and chronic immune reactions after penetrating keratoplasty with normal immune risk].
    Reinhard T; Hutmacher M; Sundmacher R
    Klin Monbl Augenheilkd; 1997 Mar; 210(3):139-43. PubMed ID: 9206744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new malononitrilamide immunosuppressant FK778 prolongs corneal allograft survival in the rat keratoplasty model.
    Birnbaum F; Schwartzkopff J; Scholz C; Reis A; Reinhard T
    Eye (Lond); 2007 Dec; 21(12):1516-23. PubMed ID: 17401326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcomes of High-Risk Keratoplasty in Patients Receiving Systemic Immunosuppression.
    Chow SP; Cook SD; Tole DM
    Cornea; 2015 Nov; 34(11):1395-9. PubMed ID: 26382894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study.
    Birnbaum F; Mayweg S; Reis A; Böhringer D; Seitz B; Engelmann K; Messmer EM; Reinhard T
    Eye (Lond); 2009 Nov; 23(11):2063-70. PubMed ID: 19151659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognosis in repeat keratoplasty: per indication analysis in a large monocentric cohort].
    Böhringer D; Reinhard T
    Klin Monbl Augenheilkd; 2008 Jan; 225(1):50-6. PubMed ID: 18236370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term graft survival after penetrating keratoplasty.
    Thompson RW; Price MO; Bowers PJ; Price FW
    Ophthalmology; 2003 Jul; 110(7):1396-402. PubMed ID: 12867398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.